Achilles Therapeutics transferred TRACERx data and samples to AstraZeneca, finalizing a strategic review and receiving $12M.

Dec 19 (Reuters) - Anglo-Swedish drugmaker AstraZeneca Plc said on Friday it signed an agreement to develop and commercialise U.S.-based MAP Pharmaceuticals' pediatric asthma drug. Sign up here ...

The Anglo-Swedish drugmaker’s closely watched weight loss pill, AZD5004, was well tolerated by patients in an early-stage clinical trial.

BANGALORE (Reuters) - MAP Pharmaceuticals said it plans to suspend development of its experimental paediatric asthma drug, after its licensing partner AstraZeneca terminated a collaboration on the ...

AstraZeneca said the Alzheimer’s drug it is codeveloping with Eli Lilly & Co. has received fast-track designation from the U.S. FDA, a status designed to speed up the development of promising ...

In the meantime, AstraZeneca faces the loss of patent protection on its cholesterol-fighting blockbuster Crestor later this year--a big sales blow, Soriot said during last quarter's earnings call ...

“Today, we announced the sale of FibroGen China to AstraZeneca, our long-time strategic partner for roxadustat in China, bolstering our company on several fronts.

In its first deal with a major drugmaker, MAP Pharmaceuticals Inc. has joined with London-based AstraZeneca to develop and commercialize a nebulized form of budesonide, a potential treatment for ...